Thygesen Group

Medicinal and organic chemistry research spanning drug discovery, sustainable chemistry and artificial enzymes. Projects combine organic synthesis, biochemical testing and molecular design to address challenges in health, sustainability and catalysis.

Research focus

Medicinal and organic chemistry 

We work in the area of organic chemistry interfacing with biochemistry. Organic synthesis plays a crucial role in most projects, and physical organic chemistry and biochemical testing a minor yet essential part. Our research areas are currently enzyme inhibitors, sustainable chemistry and artificial enzymes.

Group leader

Research

  • Development of enzyme inhibitors as potential treatments for lysosomal storage diseases.
  • Organic synthesis of biologically active molecules and candidate drug compounds.
  • Sustainable chemistry approaches for converting carbohydrate biomass into valuable chemicals.
  • Design and optimisation of artificial enzymes based on cyclodextrin systems.
  • Integration of organic chemistry, biochemistry and catalytic studies to understand molecular function.
  • Development of new catalytic systems for applications in health, sustainability and chemical synthesis.

Projects

Medicinal. 

We are looking for inhibitors of human acid β-glycosidase as potential drugs vs lysomal storage disease. A typical project is synthesis of one more inhibitor candidates and possible testing.

Sustainable chemistry.

Projects on improving the methods for conversion of carbohydrate biomass to useful compounds are available. 

Artificial enzymes.

We are working on improving our artificial enzymes build from cyclodextrins. A typical project is synthesis of one more enzyme candidates and testing it for catalysis.

Contact

Mikkel Boas Thygesen
Associate Professor
  • Job responsibility
    Group leader - Office: B520